Title |
Treatment options for infections caused by multidrug-resistant Gram-negative bacteria: a guide to good clinical practice
|
---|---|
Published in |
Future Microbiology, May 2023
|
DOI | 10.2217/fmb-2022-0160 |
Pubmed ID | |
Authors |
Khadijeh Delroba, Maryam Alaei, Hossein Khalili |
Abstract |
The rapid emergence of multidrug-resistant Gram-negative bacterial infections necessitates the development of new treatments or the repurposing of available antibiotics. Here, treatment options for treatment of these infections, recent guidelines and evidence are reviewed. Studies that included treatment options for infections caused by multidrug-resistant Gram-negative bacteria (Enterobacterales and nonfermenters), as well as extended-spectrum β-lactamase-producing and carbapenem-resistant bacteria, were considered. Potential agents for the treatment of these infections, considering type of microorganism, mechanism of resistant, source and severity of infection as well as pharmacotherapy considerations, are summarized. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Peru | 1 | 20% |
Australia | 1 | 20% |
United Kingdom | 1 | 20% |
Unknown | 2 | 40% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 4 | 80% |
Scientists | 1 | 20% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 2 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 1 | 50% |
Unknown | 1 | 50% |
Readers by discipline | Count | As % |
---|---|---|
Agricultural and Biological Sciences | 1 | 50% |
Unknown | 1 | 50% |